Notes to editor
This press release accompanies a presentation at ESC Congress 2025.
It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 6 61 40 18 84
Email: press@escardio.org
Follow European Society of Cardiology News on LinkedIn
Funding: The study was funded by the Medical Research Agency of Poland.
Disclosures: Professor Szczeklik reports no conflicts of interest.
References and notes:
1‘PREVENT-MINS trial: Ivabradine for prevention of myocardial injury after noncardiac surgery’ presented during HOT LINE 5 on 30 August 2025 at 17:45 to 17:55 in Madrid (Main Auditorium).
2Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study Investigators. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019;191:E830–E837.
3Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64:2406–2425.
About ESC Congress 2025
It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Madrid and online – from 29 August to 1 September 2025. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.
About the European Society of Cardiology
The ESC brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.